A New Jersey-based drugmaker announced this week that beginning in December, its 340B contract pharmacy restrictions will apply to Health [...] …
Year: 2024
A Washington state hospital on Tuesday became the fifth provider to sue the federal government for authorizing Johnson & Johnson [...] …
Four drugmakers are urging a federal appeals court to affirm a lower court’s decision to dismiss a California health system’s [...] …
Editor’s Note: With 340B-related litigation heating up in several states following the enactment of new contract pharmacy access laws, 340B [...] …
An organization that describes itself as being “comprised of dozens of national, public health, patient advocacy and multicultural organizations,” but [...] …
The growth in total 340B purchases last year was largely a result of drugmaker price increases and broader healthcare trends, [...] …
A California-based healthcare startup recently announced that it has raised more than $30 million, as part of a campaign with [...] …
SPONSORED CONTENT
The phrase “we’re scheduling an audit” generally triggers angst, tension and even fear. Audits of your 340B operations look deeply into your prescription records and billing procedures. They are complex and require a great deal of preparation and
…
The 340B drug discount program continued to be a hot topic for lobbyists in the third quarter of 2024, keeping [...] …
Drug purchases under the 340B program reached $66.3 billion in 2023, marking a 24% increase over the $54 billion in [...] …